Navigation Links
Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
Date:10/5/2010

duct Safety InformationDo not administer Neulasta or NEUPOGEN to patients with a history of serious allergic reactions to pegfilgrastim or filgrastim.  NEUPOGEN is contraindicated in patients with known hypersensitivity to E. coli-derived proteins, such as filgrastim.

Serious allergic reactions, including anaphylaxis, can occur in patients receiving Neulasta or NEUPOGEN. Permanently discontinue Neulasta or NEUPOGEN in patients with serious allergic reactions.

Splenic rupture, including fatal cases, can occur following the administration of Neulasta and NEUPOGEN.  

Acute respiratory distress syndrome (ARDS) can occur in patients receiving Neulasta or NEUPOGEN.

Alveolar hemorrhage, manifesting as pulmonary infiltrates and hemoptysis requiring hospitalization, has been reported in healthy donors undergoing peripheral blood progenitor cell mobilization, an unapproved use of NEUPOGEN.  Hemoptysis resolved with discontinuation of NEUPOGEN.

Bone pain and pain in extremity occurred at a higher incidence in Neulasta-treated patients as compared with placebo-treated patients. In clinical trials involving NEUPOGEN, bone pain was most frequently reported adverse event.

Important European Product Safety InformationFor full prescribing information please see the Summary of Product Characteristics for each product.

NEUPOGEN is indicated for reduction in duration of neutropenia and incidence of febrile neutropenia after established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes); reduction in duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. The safety and efficacy of NEUPOGEN are similar in adults and children receiving cytotoxic chemotherapy. NEUPOGEN is indicated for mobilisation of peripheral blood progenitor cells (PB
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Oct. 24, 2014  As the building blocks ... company access to diverse skill sets and expertise, ... clock business hours for efficiency. However, effectively managing ... According to recent research, more than ... seeing a project not move forward due to ...
(Date:10/22/2014)... , Oct. 22, 2014  Quest Diagnostics (NYSE: ... information services, today announced that its Board of Directors ... a director, effective December 1, 2014. Including Dr. Leiden, ... is the Chairman, President and CEO of Vertex Pharmaceuticals. ... scientific and commercial experience in the pharmaceutical and biotechnology ...
(Date:10/22/2014)... , Oct. 22, 2014   Reproductive ... world-renowned leader in the field of infertility, presents ... to embryonic screening. The research abstract, released during ... Reproductive Medicine (ASRM) meeting in Honolulu, ... and single gene defect (SGD) pre-implantation genetic diagnosis ...
Breaking Medicine Technology:Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3
(Date:10/25/2014)... October 25, 2014 Mesothelioma researchers are ... to receive pemetrexed (Alimta), after his combination drug therapy ... full story , just posted on the Surviving Mesothelioma ... Tokushukai Medical Center in Japan suggests that “maintenance therapy” ... patients who cannot tolerate higher doses of cisplatin. ...
(Date:10/25/2014)... 2014 (HealthDay News) -- Not getting the right amount ... a new study suggests. Those who sleep less ... per night may be more prone to developing the ... report. The study authors concluded that duration and quality ... patients with inflammatory bowel diseases. "Both short and ...
(Date:10/25/2014)... Randy Dotinga HealthDay Reporter ... tests are developed that spot increased risks for certain cancers, ... about getting screened. But a new study suggests that, ... People who found out their genes doubled their risk of ... risk to get screened. "It didn,t make any difference, ...
(Date:10/22/2014)... TX (PRWEB) October 22, 2014 On ... Criminal Minds featuring skin diseases both fictional and ... (CEHMDF), a nonprofit organization committed to advocacy and ... if CBS will take the opportunity to impart truth ... , There are many misconceptions about ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... Ebola cases in Dallas. But, mental health specialists say overblown ... President Barack Obama on Friday appointed an Ebola "czar" to ... two Dallas nurses who cared for a Liberian man who ... But the U.S. cases are miniscule in the context ...
Breaking Medicine News(10 mins):Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3
... A drug whose clinical benefit in treating multiple sclerosis was ... Food and Drug Administration on January 22 and is now ... is the first therapy for multiple sclerosis that can be ... to treat impaired walking, a debilitating symptom of the disease ...
... ... renewed its multi year relationship with Seventh Generation, the leading global brand of green ... paper towels. , ... Hong Kong, China (April 1, 2010) – Serendipity House Limited, Hong Kong’s leading provider ...
... ... a new survey of U.S. healthcare organizations suggests that while organizations are updating their ... ... the healthcare industry prepares for a major shift to electronic health records (EHRs) over ...
... ... Techniques Are Impacting the Face of the Senior Care Industry , ... Newport Beach, Calif. (PRWEB) April 5, ... on how elder care marketers grow their businesses. The Elder Care Marketing Industry Report, ...
... discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has ... of conflicting data concerning XMRV, standardized diagnostic testing is ... and to determine whether it plays a role in ... the April issue of Urology is a ...
... Research on antibodies may aid vaccine development , MONDAY, April ... insight into how the body fights off HIV, a finding ... the virus, which causes AIDS. , At the moment, there,s ... develop a vaccine. HIV remains an extremely stubborn enemy. , ...
Cached Medicine News:Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 3Health News:Serendipity House Limited, the Leading Provider of Natural and Organic Products in Hong Kong, Renews Multi-year Relationship with Seventh Generation 2Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 2Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 3Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 4Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 5Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 6Health News:Healthcare Industry Continues to Overlook Critical Gaps in Data Security, According to New Bi-Annual Report 7Health News:New Study on Elder Care Marketing Reveals Fresh Insights in Targeting Aging Population 2Health News:New Study on Elder Care Marketing Reveals Fresh Insights in Targeting Aging Population 3Health News:New investigation supports correlation between XMRV and prostate cancer 2Health News:Scientists Find Clues to How the Body Fights Off HIV 2
... Blood Collection Tubes were designed for ease ... a quality capillary blood sample is collected. ... Microgard Closure features an integrated collection scoop ... of microcollection tubes is available for hematology ...
... PT System is an in vitro diagnostic ... results, expressed in seconds and INR units. ... It is intended for use by health ... to monitor patients who are on warfarin-type ...
... IntelliVue Information Center combines the real-time ... with sophisticated clinical analysis tools. Moreover, ... Philips innovative portal technology so that ... by side with digital radiology images, ...
... GenS automates time-consuming tasks ... to help increase productivity and ... high-volume lab. It offers automated ... technology, which provides excellent sensitivity, ...
Medicine Products: